Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate Adenocarcinoma
Clinical trial NCT07316686 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07316686
- Sponsor
- Instituto do Cancer do Estado de São Paulo
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2026-09-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.